Antibacterial Effect and Mechanism of Chelerythrine on Xanthomonas oryzae pv. oryzae

Yi Yan1,2, Jueyu Wang1,2, Na Zhao1,2

  • 1College of Life Science, Northeast Forestry University, Harbin 150040, China.

Microorganisms
|April 26, 2025
PubMed

Insights

Chelerythrine, a plant-derived compound, effectively inhibits Xanthomonas oryzae pv. oryzae (Xoo) growth and pathogenicity. This natural antimicrobial agent disrupts bacterial cell division, membrane integrity, and metabolism, offering a promising new strategy against bacterial blight.

Area of Science:

  • Plant biochemistry
  • Microbiology
  • Bacteriology

Background:

  • Xanthomonas oryzae pv. oryzae (Xoo) causes significant global crop losses due to bacterial blight.
  • Existing treatments face challenges with resistance and environmental impact.
  • Plant-derived compounds offer potential for novel antimicrobial strategies.

Purpose of the Study:

  • To investigate the antimicrobial effects of chelerythrine against Xoo.
  • To elucidate the mechanism of action of chelerythrine on Xoo.

Main Methods:

  • Determined the minimum inhibitory concentration (MIC) of chelerythrine against Xoo.
  • Assessed the impact of chelerythrine on Xoo cell morphology and division.
  • Analyzed chelerythrine's effects on Xoo cell membrane permeability, pathogenicity factors (extracellular polysaccharide, cellulase, biofilm), reactive oxygen species (ROS) production, and key metabolic pathways.

Main Results:

  • Chelerythrine significantly inhibited Xoo growth at 1.25 μg/mL, inducing filamentous growth.
  • It disrupted Xoo cell membrane integrity, reduced pathogenicity factors, and increased ROS accumulation.
  • Mechanisms included inhibition of Z-ring formation, nucleotide synthesis, DNA repair, peptidoglycan, and lipid-A synthesis, alongside interference with carbohydrate metabolism.

Conclusions:

  • Chelerythrine exhibits multi-target antimicrobial properties against Xoo at low concentrations.
  • Its ability to disrupt multiple essential bacterial processes makes it a potent candidate for novel antibacterial development.
  • These findings support the use of chelerythrine as a basis for developing effective, plant-derived antimicrobials against Xoo.

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
976
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
473
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
557
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.6K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.0K